Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Public Health Dent ; 59(4): 263-8, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10682334

RESUMO

The milder forms of dental fluorosis have increased in prevalence since the original epidemiologic surveys of the 1930s. Most studies of fluorosis have identified the use of supplements as a major risk factor. Fluorosis could be prevented, in part, by stopping the improper prescription of fluoride supplements in optimally fluoridated areas and by lowering the dosage currently recommended by the Council on Dental Therapeutics supplemental fluoride schedule. At a 1991 workshop at the University of North Carolina, five alternatives to the present ADA Council on Dental Therapeutics schedule were suggested; however, no consensus on dosage was reached. Recently, the Fédération Dentaire International adopted a dosage schedule of 0.25 mg F from birth to 3 years of age, 0.5 mg F from 3 to 5 years, and 1 mg F thereafter. At a 1992 Canadian workshop it was proposed that supplements should not be started until age 3, should be given only to those "at high risk" of caries, and only 0.25 mg F should be prescribed from 3 to 5 years of age. Similarly, in some European countries supplements are not recommended until 3 years, at which time 0.5 mg F is prescribed, but only "for children at risk." Australia is considering a dosage schedule starting with 0.25 mg F at 6 months, again only for those "particularly at risk of caries." Serious problems exist in limiting fluoride supplementation only to high-caries-risk children because they are not easily identifiable at a young age. Ideally, a dosage schedule should be based on body surface area or weight rather than simply age, and supplements should be in the form of lozenges for children over 2 years of age. A reduced fluoride supplement dosage schedule is proposed.


Assuntos
Cariostáticos/administração & dosagem , Suplementos Nutricionais , Fluoretos/administração & dosagem , Fatores Etários , American Dental Association , Austrália , Canadá , Cariostáticos/efeitos adversos , Criança , Pré-Escolar , Cárie Dentária/prevenção & controle , Suscetibilidade à Cárie Dentária , Esquema de Medicação , Europa (Continente) , Fluoretos/efeitos adversos , Fluorose Dentária/etiologia , Fluorose Dentária/prevenção & controle , Humanos , Lactente , Recém-Nascido , Fatores de Risco , Sociedades Odontológicas , Comprimidos , Estados Unidos
2.
Compend Contin Educ Dent Suppl ; 18(21): S2-7; quiz S45, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-12017930

RESUMO

Early dentifrices contained natural ingredients, mostly in coarse particle form, and were quite abrasive. Salts, either sodium chloride, sodium bicarbonate, or a mixture of both, have also been used for tooth cleaning because of their ready availability and low cost. Because of both their relatively low intrinsic hardness and their high solubility, another advantage is low abrasivity. Their biggest disadvantage is a salty, unpalatable taste. Many modern dentifrices that contain sodium bicarbonate, either as the sole abrasive or one of several, disguise the saltiness with flavoring and sweetening agents. An almost inverse relationship exists between the percentage of baking soda in a dentifrice and its abrasivity. Sodium bicarbonate has no anticaries activity per se but is compatible with fluoride. In high concentrations, sodium bicarbonate is bactericidal against most periodontal pathogens. Most clinical studies have not found significant differences in periodontal response to baking soda as compared with other commercial dentifrices, probably because of its rapid clearance from the gingival sulcus. Sodium bicarbonate may not be the "magic bullet" for curing dental diseases, but its safety (if ingested), low abrasivity, low cost, and compatibility with fluoride make it a consummate dentifrice ingredient.


Assuntos
Dentifrícios/química , Bicarbonato de Sódio/uso terapêutico , Placa Dentária/prevenção & controle , Dentifrícios/efeitos adversos , Dentifrícios/história , Combinação de Medicamentos , Egito , Europa (Continente) , Dureza , História do Século XVII , História do Século XIX , História do Século XX , História Antiga , História Medieval , Humanos , Peróxido de Hidrogênio , Higiene Bucal/métodos , Abrasão Dentária/etiologia , Estados Unidos
3.
J Dent Res ; 71(5): 1255-65, 1992 May.
Artigo em Inglês | MEDLINE | ID: mdl-1607443

RESUMO

In recent years, an increase in the prevalence of dental fluorosis, mostly of the very mild to mild category, has been seen in the United States. This paper therefore discusses the safety of dental fluoride products, primarily with respect to the risk of dental fluorosis due to chronic ingestion of these products by pre-school children. No change is indicated in the optimal fluoride level (0.7 to 1.2 ppm) for water fluoridation. A reduction in the dosage of fluoride supplements is recommended for children aged from three to six years (14.5 to 22 kg body weight) residing in communities with less than 0.7 ppm F. Physicians, pharmacists, and dentists need to be better educated in correctly prescribing fluoride supplements; such prescriptions should be based on the fluoride concentration of the domestic water supply and the child's weight/height/age. No change is recommended in the concentration of fluoride used in dentifrices and mouthrinses. The US Food and Drug Administration should require more explicit labeling of fluoride products with regard to avoidance of ingestion, use of small amounts, and need for supervised use by pre-school children. The efficacy of water fluoridation, fluoride supplements, and topical fluoride agents has been amply documented elsewhere.


Assuntos
Fluoretação , Fluoretos Tópicos/uso terapêutico , Fluoretos/uso terapêutico , Criança , Pré-Escolar , Protocolos Clínicos , Fluoretos/administração & dosagem , Humanos
4.
Am J Clin Nutr ; 36(2): 211-8, 1982 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7102580

RESUMO

In a program of studies of disuse osteoporosis, fluoride balances were determined in healthy men during ambulation and then during bed rest for 6 to 17 wk. Control subjects ingested basal diets containing 0.4 mg fluoride per day, whereas experimental subjects received 10-mg fluoride supplements in divided doses with meals. Fluoride and calcium were measured in diets, urine, and feces. Serum analyses included calcium and ionic fluoride. Fluoride balances during both phases were uniformly negative in control subjects (mean -0.46 mg/day) but uniformly positive in supplement subjects (mean +2.58 mg/day). Calcium balances were markedly negative during bed rest in both groups. Serum fluoride concentrations increased proportionally to fluoride intake, averaging 0.016 ppm in the controls and 0.045 ppm in the supplement subjects. The supplement of 10 mg fluoride daily did not protect against bed rest-induced calcium loss, or cause any clinical or laboratory abnormality in any subject.


Assuntos
Repouso em Cama , Fluoretos/uso terapêutico , Alimentos Fortificados , Osteoporose/prevenção & controle , Fluoreto de Sódio/uso terapêutico , Adulto , Cálcio/análise , Fluoretos/análise , Fluoretos/fisiologia , Homeostase , Humanos , Locomoção , Masculino
5.
J Dent Res ; 59(1): 23-8, 1980 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-6927982

RESUMO

Children rinsed twice daily with one of two concentrations of calcium glycerophosphate or a placebo. Plaque was collected at two-week intervals for eight weeks, and Löe and Silness Indices determined. Results indicate a lower index rating and a higher phosphorus content for experimental groups than for the control at the four-week examination.


Assuntos
Fosfatos de Cálcio/farmacologia , Placa Dentária/análise , Glicerofosfatos/farmacologia , Antissépticos Bucais/farmacologia , Adolescente , Placa Dentária/etiologia , Feminino , Humanos , Masculino , Fósforo/análise , Placebos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA